 RANCHO CUCAMONGA, CA ACCESSWIRE September 2, 2021 Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P. 